Recall Register

Food, drugs, devices › Carestream Health Inc

Device recall: DRX-Revolution Mobile X-Ray System; MODEL DRXR-1; Catalog # 1019397 (all other countries) and Catalog 1060177 (China onl

FDA enforcement event 77250 · Class II · initiated 25 May 2017 · status Terminated · terminated 13 Jun 2018

DeviceVoluntary: Firm initiated1 product recordRochester, NY

Carestream Health Inc (Rochester, NY) initiated this device recall on 25 May 2017; FDA lists 1 product record under event 77250, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 13 Jun 2018. Initiation: voluntary: firm initiated. Carestream Health Inc has 30 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Carestream Health Inc, Rochester, NY.

Reason for recall

"Carestream found a single unit where four screws in the assembly were not applied in the manufacturing process. This could result in separation of the tube and yoke assembly."

Distribution

"Worldwide Distribution - US (nationwide) Internationally to Australia, Brazil, Canada, Chile, China, Colombia, Dominican Republic, India, Japan, Israel, Korea, Malaysia, Maldives, Mexico, New…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2651-2017DRX-Revolution Mobile X-Ray System; MODEL DRXR-1; Catalog # 1019397 (all other countries) and Catalog 1060177 (China only) -- COMMON/USUAL NAME: DRX-Revolution --- The DRX-Revolution is a mobile system used to generate and control X-Rays for diagnostic proceduresDomestic: 1449 units; Foreign: 1416 unitsClass IITerminated5 Jul 2017

Context

93%of 2017 device events are Class II1,091 events that year
1product record in this eventfirm median: 1
30events on this register for the firm

Other enforcement events for Carestream Health Inc

InitiatedProduct (first record)TypeClassRecords
2 Oct 2023DRX Revolution Mobile X-Ray SystemDeviceClass II1
2 Oct 2023The DRX-Revolution Mobile X-Ray System is a diagnostic mobile x-ray system utilizing digital radiography (DR) technologyDeviceClass II1
30 Jan 2023DRX-Compass/DR-FIT X-ray Systems with Firmware version 2.3.2.0/2.3.2.4. For use in obtaining diagnostic quality radiograDeviceClass II1
6 Jan 2020Kodak DirectView DR3000/3500 - Product Usage: permanently installed as a diagnostic system intended to generate and contDeviceClass II1
19 Mar 2019OnSight 3D Extremity System- X-Ray, Tomography Computed System Catalog Numbers: 1743566 (w/ Attached Console) 1743574 (wDeviceClass II1
12 Jan 2017Carestream DRX-Revolution Mobile X-Ray System, Model DRXR-1, Catalog No. 1019397 (all other countries), Catalog No. 1060DeviceClass II1
21 Nov 2016Carestream Touch Prime, Catalog # 1738830, and Touch Prime XE, Catalog # 1738822, Ultrasound System Diagnostic ultrasounDeviceClass II1
8 Jul 2016Carestream Touch Prime, Catalog Number 1738830, and Carestream Touch Prime XE, Catalog Number 1738822 --- Common Name: TDeviceClass II1
15 Apr 2016CARESTREAM Image Suite V3: MINI-PACS/F IMG ST/CLASSIC: REF/Catalog # 1036490; MINI-PACS/F IMG ST/POC&VITA: REF/Catalog #DeviceClass II2
7 Aug 2015CARESTREAM DRX-EVOLUTION X-Ray System Product Usage: The device is a permanently installed diagnostic X-ray system for gDeviceClass II1

All 30 events for Carestream Health Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Carestream found a single unit where four screws in the assembly were not applied in the manufacturing process. This could result in separation of the tube and yoke assembly."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US (nationwide) Internationally to Australia, Brazil, Canada, Chile, China, Colombia, Dominican Republic, India, Japan, Israel, Korea, Malaysia, Maldives, Mexico, New…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 13 Jun 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.